Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01811004 · ClinicalTrials.gov registry record · NA
Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01811004 is a NA study that has completed, run by Cynosure. The registered enrollment target is 17 participants.
The verdict
NCT01811004, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The Purpose of the study is to evaluate the 1440nm Laser Assisted Selective Photothermolysis vs. Botulinum Toxin or miraDry® Microwave Thermolysis For Treatment of Axillary Hyperhidrosis.
Interventions
- DEVICE miraDry
- DEVICE Nd:YAG Laser
- DEVICE Botox®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01811004
The ClinicalTrials.gov registry entry for NCT01811004 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which miraDry is the first listed.
NCT01811004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01811004 about?
NCT01811004 is a clinical study titled "Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis". The Purpose of the study is to evaluate the 1440nm Laser Assisted Selective Photothermolysis vs. Botulinum Toxin or miraDry® Microwave Thermolysis For Treatment of Axillary Hyperhidrosis.
What is the current status of trial NCT01811004?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2012-09. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01811004?
The interventions under investigation include: miraDry (DEVICE), Nd:YAG Laser (DEVICE), Botox® (DEVICE).
Who is sponsoring clinical trial NCT01811004?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.